Disopyramide concentrations in saliva.
The saliva and plasma concentrations of disopyramide and its main metabolite, mono-N-dealkyldisopyramide, and the protein binding of disopyramide were studied in ten healthy volunteers after a single oral 400-mg dose of disopyramide. Disopyramide had a concentration-dependent inhibitory effect on the salivary flow rate. The correlations between the salivary and total plasma concentrations of disopyramide (r = 0.774 linear, 0.890 exponential, p less than 0.0001), of the metabolite (r - 0.700, p less than 0.001), and between the salivary and free plasma concentrations of disopyramide (r = 0.785, p less than 0.001) were relatively good. The fraction of disopyramide not bound to plasma proteins varied from not measurable to 0.35, was concentration-dependent, and showed intersubject variation. The ratio of disopyramide concentrations in saliva and plasma (S/P ratio) varied from 0.08 to 1.51 and was highest when the salivary and plasma levels were high. No significant correlation existed between S/P ratio and salivary pH, and the correlation was poor (r = 0.546) between the measured salivary concentrations and those calculated theoretically. A wide interindividual variation was seen in all parameters measured. The salivary concentrations of disopyramide are unreliable for predicting the corresponding total or free plasma concentrations.
D000328:Adult; D001798:Blood Proteins / Q000378:metabolism; D004206:Disopyramide / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D011485:Protein Binding; D011725:Pyridines / Q000378:metabolism*; D012463:Saliva / Q000378:metabolism*; D013997:Time Factors
D001798:Blood Proteins; D011725:Pyridines; D004206:Disopyramide